FindTrial
Sign In

The effect of neoadjuvant immunotherapy on perioperative endocrine function and intraoperative hemodynamics in patients with gastrointestinal tumors: a single center retrospective cohort study

The effect of neoadjuvant immunotherapy on perioperative endocrine function and intraoperative hemodynamics in patients with gastrointestinal tumors: a single center retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104744
Enrollment
Unknown
Registered
2025-06-23
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer

Interventions

Neoadjuvant immunotherapy:None
chemotherapy:None

Sponsors

Beijing Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosed as malignant tumor of the stomach or colon; 2. Elective surgical resection.

Exclusion criteria

Exclusion criteria: 1. Merge patients with primary tumors in other parts; 2. Patients with recurrent gastrointestinal tumors; 3. Patients who are found to be unable to undergo curative resection or undergo combined resection of other organs during surgery; 4. Patients with missing data.

Design outcomes

Primary

MeasureTime frame
Endocrine function;Perioperative hemodynamic changes;—

Secondary

MeasureTime frame
Postoperative complications;Reoperation;—

Countries

China

Contacts

Public ContactTan Hongyu

Beijing Cancer Hospital

maggitan@yeah.net+86 184 1006 4060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026